Pediatric Bulimia

A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder

Condition:   Binge Eating Disorder
Interventions:   Drug: dasotraline 4mg;   Drug: dasotraline 6mg;   Drug: Placebo
Sponsor:   Sunovion
Recruiting - verified May 2017

Light Therapy and Binge Eating Disorder Treatment (BED Light Study)

Condition:   Binge-Eating Disorder
Interventions:   Device: High intensity bright light therapy;   Device: Low intensity light therapy
Sponsor:   Hospices Civils de Lyon
Not yet recruiting - verified March 2017

Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder

Conditions:   Eating Disorder;   Bulimia Nervosa;   Binge Eating Disorder
Interventions:   Behavioral: Adaptive Recovery Record App;   Behavioral: Standardized Coaching
Sponsor:   Nova Scotia Health Authority
Not yet recruiting - verified January 2017

Neural Bases of Multiple Forms of Self-regulatory Control in Bulimia Nervosa

Condition:   Bulimia Nervosa
Sponsors:   University of California, San Diego;   National Institute of Mental Health (NIMH);   The Hilda & Preston Davis Foundation
Recruiting - verified December 2016

Dialectical Behavior Therapy Guided Self-Help for Binge Eating Disorder

Condition:   Binge Eating Disorder
Interventions:   Behavioral: DBT Guided Self-Help;   Behavioral: DBT Unguided Self-Help;   Behavioral: Self-Esteem-Focused Unguided Self-Help
Sponsor:   Memorial University of Newfoundland
Not yet recruiting - verified July 2016

Food Response Training for Binge Eating

Condition:   Binge Eating
Interventions:   Behavioral: Go/No-Training;   Behavioral: Stop-Signal Training;   Behavioral: Dot-Probe Paradigm;   Behavioral: Generic Response Training
Sponsors:   Loma Linda University;   Oregon Research Institute
Recruiting - verified January 2017

Improving Behavioral Treatments for Bulimia Nervosa- The INSPIRE Project: Innovations in Psychological Interventions for Regulating Eating

Conditions:   Bulimia Nervosa;   Bulimia;   Binge Eating;   Purging (Eating Disorders);   Eating Disorder
Interventions:   Behavioral: Nutritional Counseling & Acceptance-based Therapy;   Behavioral: Cognitive Behavioral Therapy for Eating Disorders
Sponsors:   Drexel University;   National Institute of Mental Health (NIMH)
Recruiting - verified April 2017

Dasotraline Binge Eating Disorder Extension Study

Condition:   Binge Eating Disorder
Intervention:   Drug: Dasotraline
Sponsor:   Sunovion
Enrolling by invitation - verified April 2017

Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)

Condition:   Binge Eating Disorder
Intervention:   Drug: PHEN/TPM ER (Qsymia®)
Sponsors:   Lindner Center of HOPE;   University of Cincinnati
Completed - verified January 2016

Dasotraline Binge Eating Disorder Study

Condition:   Binge Eating Disorder
Interventions:   Drug: Dasotraline;   Drug: Placebo
Sponsor:   Sunovion
Completed - verified November 2016

Noom Monitor for Binge Eating

Condition:   Binge Eating Disorder
Intervention:   Behavioral: CBT-GSH with Noom Monitor
Sponsors:   Icahn School of Medicine at Mount Sinai;   Noom Inc.;   Kaiser Permanente
Recruiting - verified November 2016

FDA Approved Medication to Reduce Binge Eating and/or Purging

Conditions:   Binge Eating Disorder;   Bulimia Nervosa
Interventions:   Drug: Phentermine/Topiramate-First;   Drug: Placebo
Sponsor:   Stanford University
Active, not recruiting - verified April 2017

Vortioxetine for Binge Eating Disorder

Condition:   Binge Eating Disorder
Interventions:   Drug: Vortioxetine;   Drug: Placebo
Sponsors:   University of Chicago;   Takeda
Recruiting - verified January 2017

Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF.

Condition:   Bulimia Nervosa
Interventions:   Drug: Antidepressants;   Drug: Positron Emission Tomography (PET)
Sponsors:   Centre Hospitalier Universitaire de Saint Etienne;   Ministry of Health, France
Recruiting - verified April 2017

Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo

Condition:   Binge Eating Disorder
Interventions:   Drug: Naltrexone and bupropion combination;   Other: Pill Placebo
Sponsor:   Yale University
Completed - verified February 2017

Virtual Reality Based Cue-exposure Treatment for Bulimia Nervosa

Conditions:   Bulimia Nervosa;   Binge-Eating Disorder;   Binge Eating
Interventions:   Behavioral: VR based cue-exposure therapy;   Behavioral: Additional Cognitive-behavioral treatment
Sponsors:   University of Barcelona;   Hospital Universitari de Bellvitge;   Consorci Sanitari de l'Anoia;   Centro ABB;   Hospital Universitari Joan XXIII de Tarragona.;   Istituto Auxologico Italiano
Completed - verified February 2017

Integrative Cognitive-Affective Therapy for Binge Eating Disorder

Condition:   Binge Eating Disorder
Interventions:   Behavioral: Integrative Cognitive-Affective Therapy;   Behavioral: CBT-Guided Self Help
Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   Neuropsychiatric Research Institute, Fargo, North Dakota
Recruiting - verified January 2017

A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating Disorder

Condition:   Binge-Eating Disorder
Interventions:   Drug: Methylphenidate;   Behavioral: Cognitive Behavioral Therapy
Sponsors:   Centre for Addiction and Mental Health;   Ontario Mental Health Foundation
Completed - verified February 2017

Bulimia Nervosa: A Biobehavioral Study (The Eating Disorder Study)

Condition:   Bulimia Nervosa
Sponsors:   Drexel University;   Columbia University;   The Miriam Hospital
Recruiting - verified March 2017

Stepped Care for Binge Eating Disorder: Predicting Response to Minimal Intervention in a Randomized Controlled Trial

Condition:   Binge Eating Disorder
Interventions:   Behavioral: Group Psychodynamic Interpersonal Psychotherapy;   Behavioral: Unguided Self-Help
Sponsors:   Ottawa Hospital Research Institute;   Ontario Mental Health Foundation
Active, not recruiting - verified October 2016

Acceptance-based Group Intervention for Binge Eating

Condition:   Binge-Eating Disorder
Interventions:   Behavioral: Acceptance and Commitment Therapy (ACT);   Behavioral: Brief MOVE-II control group intervention
Sponsor:   VA Office of Research and Development
Completed - verified October 2016

Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese

Condition:   Binge Eating Behaviour
Interventions:   Drug: Liraglutide;   Behavioral: Diet and Exercise
Sponsor:   Universiti Kebangsaan Malaysia Medical Centre
Completed - verified May 2017

Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder

Condition:   Binge Eating Disorder
Interventions:   Drug: lisdexamfetamine;   Drug: Placebo control
Sponsors:   Lindner Center of HOPE;   Shire;   University of Cincinnati
Completed - verified July 2016

Online Cognitive Behavioral Therapy for Bulimia Nervosa

Condition:   Bulimia Nervosa
Intervention:   Behavioral: Cognitive Behavioral Group Therapy
Sponsors:   University of North Carolina, Chapel Hill;   National Institute of Mental Health (NIMH)
Completed - verified June 2016

Effect of a CCK-1R Agonist on Food Intake in Humans

Condition:   Bulimia
Interventions:   Drug: GSKI181771X (CCK-1R agonist);   Behavioral: Instructions to binge eat;   Behavioral: Instructions to eat normally;   Drug: Placebo
Sponsors:   St. Luke's-Roosevelt Hospital Center;   GlaxoSmithKline
Terminated - verified April 2017

Refine Your Search Advanced Search